MPs, experts and families affected by the rare neurodegenerative disease Friedreich's Ataxia (FA) called on the government this month to enable interim access to a drug for which UCLH and UCL led the ...

Risk calculators that doctors use to estimate a person’s risk of a heart attack or stroke work about as well for predicting certain cancers, according to a new study by UCL researchers.The tools are u...

A new treatment for early Alzheimer’s disease has shown encouraging results with UCLH consultant, Prof Cath Mummery, reporting both slower cognitive decline and significant reductions in the tau prote...

Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggr...

Trauma patients urgently requiring a breathing tube are more likely to survive if the tube is inserted before arriving at hospital compared to insertion afterwards, suggests a modelling study led by r...

The neurosurgeon leading the trial tells Sky News the level of control the Neuralink chip offers is "mindblowing" and will be a "game-changer".

There are now seven patients participating in the GB-PRIME study involving Neuralink’s brain-computer interface (BCI) technology, which aims to improve independence for people who are paralysed.

Be part of UCLH’s Celebrating Research Open Day on 9 July 2026 - an interactive event highlighting innovation and cutting-edge healthcare advancements to hospital staff, patients and the public.

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, following landmark findings from a clinical trial co-led by an oncology consultant ...

People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficienci...

A new daily pill has shown continuous, round-the-clock control of high blood pressure in people whose condition is difficult to manage, according to a global study led by Professor Bryan Williams, UCL...

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major c...

UCLH has recruited the first participant in the UK for a study testing a new anti-cancer treatment combination for advanced solid tumours such as endometrial and ovarian cancers. This global study, ta...

A UK patient with multiple sclerosis (MS) is the first to receive CAR T cell therapy in a BRC supported trial testing whether this personalised treatment may slow or even halt the progression of the d...

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at UCL and Newcastle University.The £26 million project is...

A UCL study shows it is possible to cut the time for diagnostic MRI scans for dementia to one third of their standard length.Shorter scans would be easier and more comfortable for patients and also me...

YouTube video by NIHR BioResource

A new gene therapy to treat Huntington’s disease known as AMT-130 has shown positive data from a study which is being run at UCLH and other sites.The phase I/II study demonstrates a statistically sign...

New medications for Alzheimer’s disease – which are not yet approved in some countries – have shown for the first time that clinical decline can be slowed with comparable effectiveness to approved med...

A major trial supported by the BRC aims to transform the diagnosis of Alzheimer’s disease through a simple blood test.The UCL-led trial is now welcoming its first participants who will be recruited vi...

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by UCL along with academics at the University of East Anglia and Guy’s and ...

A new treatment has been shown to significantly lower blood pressure in people whose levels stays dangerously high, despite taking several existing medicines, according to the results of a Phase III c...

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by UCL along with academics at the University of East Anglia and Guy’s and ...

When given nutritionally matched diets, participants lost twice as much weight eating minimally processed foods compared to ultra-processed foods, suggesting that cutting down on processing could help...

Response rates to immunotherapy treatment for prostate cancer patients improves markedly when specific molecular features of the tumour are selected for, compared to trials in unselected patients, sho...